Xu Cao

1.8k total citations
38 papers, 1.1k citations indexed

About

Xu Cao is a scholar working on Molecular Biology, Sensory Systems and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xu Cao has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Sensory Systems and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xu Cao's work include Ion Channels and Receptors (12 papers), Ion channel regulation and function (8 papers) and Connexins and lens biology (5 papers). Xu Cao is often cited by papers focused on Ion Channels and Receptors (12 papers), Ion channel regulation and function (8 papers) and Connexins and lens biology (5 papers). Xu Cao collaborates with scholars based in China, United States and Hong Kong. Xu Cao's co-authors include Irina G. Obrosova, D. A. Greene, Carol Van Huysen, KeWei Wang, Jie Zheng, Martin Stevens, Fan Yang, Yuanyuan Cui, Linlin Ma and Vladimir Yarov‐Yarovoy and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and FEBS Letters.

In The Last Decade

Xu Cao

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Cao China 17 414 383 284 197 107 38 1.1k
Valério Farfariello Italy 22 530 1.3× 548 1.4× 184 0.6× 147 0.7× 111 1.0× 37 1.3k
Jesse Peterson United States 14 333 0.8× 239 0.6× 118 0.4× 152 0.8× 161 1.5× 19 1.1k
Jennifer V. Bodkin United Kingdom 15 368 0.9× 321 0.8× 240 0.8× 148 0.8× 86 0.8× 16 1.2k
Kazuya Togashi Japan 10 780 1.9× 399 1.0× 446 1.6× 332 1.7× 211 2.0× 15 1.4k
Gregor Bahrenberg Germany 21 224 0.5× 584 1.5× 304 1.1× 90 0.5× 114 1.1× 44 1.4k
Jae Yeoul Jun South Korea 24 735 1.8× 1.2k 3.1× 371 1.3× 349 1.8× 184 1.7× 89 2.3k
Xiangyu Cai China 12 505 1.2× 563 1.5× 89 0.3× 317 1.6× 49 0.5× 16 1.1k
Min Seuk Kim South Korea 21 786 1.9× 905 2.4× 120 0.4× 373 1.9× 171 1.6× 47 1.7k
Kirill Essin Germany 17 762 1.8× 729 1.9× 379 1.3× 379 1.9× 204 1.9× 19 1.8k
Oliver G. Rößler Germany 27 250 0.6× 1.0k 2.7× 102 0.4× 255 1.3× 69 0.6× 68 1.7k

Countries citing papers authored by Xu Cao

Since Specialization
Citations

This map shows the geographic impact of Xu Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Cao more than expected).

Fields of papers citing papers by Xu Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Cao. The network helps show where Xu Cao may publish in the future.

Co-authorship network of co-authors of Xu Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Cao. A scholar is included among the top collaborators of Xu Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Cao. Xu Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Erwei, Yue Yin, Jiuda Zhao, et al.. (2025). LBA25 Culmerciclib plus fulvestrant as first-line treatment for HR+/HER2- advanced breast cancer: A phase III trial (CULMINATE-2). Annals of Oncology. 36. S1569–S1570. 1 indexed citations
2.
Li, Zhaohuan, Xuebing Liu, Lan Deng, et al.. (2024). Study on the characteristics of carotid wall shear stress in type 2 diabetes patients based on ultrasound vector flow imaging. Frontiers in Endocrinology. 15. 1409082–1409082.
3.
Liu, Ming-wei, Xiaoguang Wu, Q. Zhang, et al.. (2024). Targeting GPR39 in structure-based drug discovery reduces Ang II-induced hypertension. Communications Biology. 7(1). 1 indexed citations
4.
Cao, Xu, Guy M. Lenk, & Miriam H. Meisler. (2023). Altered phenotypes due to genetic interaction between the mouse phosphoinositide biosynthesis genes Fig4 and Pip4k2c. G3 Genes Genomes Genetics. 13(8). 3 indexed citations
5.
Li, Hongpeng, Shizhong Cai, Xia Chen, et al.. (2023). The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo. Cell Death and Disease. 14(5). 307–307. 9 indexed citations
6.
Hu, Linghan, Xu Cao, Jiahui Zhao, et al.. (2020). Genotype‒Phenotype Correlation of TRPV3-Related Olmsted Syndrome. Journal of Investigative Dermatology. 141(3). 545–554. 25 indexed citations
7.
Chan, Kevin C., Yu Yu, Heather Mak, et al.. (2019). Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma. Acta Biomaterialia. 94. 219–231. 33 indexed citations
8.
Zhang, Qitao, Kecia L. Feathers, Xu Cao, et al.. (2018). A platform for assessing outer segment fate in primary human fetal RPE cultures. Experimental Eye Research. 178. 212–222. 9 indexed citations
9.
Zhang, Jie, Lina Duo, Zhimiao Lin, et al.. (2015). Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis. Gene. 566(1). 84–88. 8 indexed citations
10.
Cao, Xu, Seok Choi, József Maléth, et al.. (2015). The ER/PM microdomain, PI(4,5)P2 and the regulation of STIM1–Orai1 channel function. Cell Calcium. 58(4). 342–348. 44 indexed citations
11.
Wang, Huijun, Xu Cao, Zhimiao Lin, et al.. (2014). Exome sequencing reveals mutation in GJA1 as a cause of keratoderma-hypotrichosis-leukonychia totalis syndrome. Human Molecular Genetics. 24(1). 243–250. 37 indexed citations
12.
Cao, Xu, et al.. (2014). A novel mutation of PAX6 identified in a Chinese twin family with congenital aniridia complicated with nystagmus. Genetics and Molecular Research. 13(4). 8679–8685. 2 indexed citations
13.
Jia, Xinying, Hong Zhang, Xu Cao, Yuxin Yin, & Bo Zhang. (2014). Activation of TRPV1 mediates thymic stromal lymphopoietin release via the Ca2+/NFAT pathway in airway epithelial cells. FEBS Letters. 588(17). 3047–3054. 34 indexed citations
14.
Cao, Xu, Linlin Ma, Fan Yang, KeWei Wang, & Jie Zheng. (2013). Divalent cations potentiate TRPV1 channel by lowering the heat activation threshold. The Journal of General Physiology. 143(1). 75–90. 41 indexed citations
16.
Cai, Suping, Yan Yin, Xu Cao, et al.. (2012). A novel MYOC heterozygous mutation identified in a Chinese Uygur pedigree with primary open-angle glaucoma.. PubMed. 18. 1944–51. 7 indexed citations
17.
Cao, Xu, Fan Yang, Jie Zheng, & KeWei Wang. (2012). Intracellular Proton-mediated Activation of TRPV3 Channels Accounts for the Exfoliation Effect of α-Hydroxyl Acids on Keratinocytes. Journal of Biological Chemistry. 287(31). 25905–25916. 54 indexed citations
18.
Cui, Yuanyuan, Fan Yang, Xu Cao, et al.. (2012). Selective disruption of high sensitivity heat activation but not capsaicin activation of TRPV1 channels by pore turret mutations. The Journal of General Physiology. 139(4). 273–283. 91 indexed citations
19.
Su, Jun, Xu Cao, & KeWei Wang. (2011). A Novel Degradation Signal Derived from Distal C-terminal Frameshift Mutations of KCNQ2 Protein Which Cause Neonatal Epilepsy. Journal of Biological Chemistry. 286(50). 42949–42958. 9 indexed citations
20.
Ren, Yan, Robert Z. Luo, Xiang Mao, et al.. (2007). Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 diabetic pedigrees. Journal of Lipid Research. 48(8). 1681–1688. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026